The Research Division of BioTelemetry

Welcome to BioTelemetry Research, formerly Cardiocore. Our acquisition by BioTelemetry, Inc. (NASDAQ: BEAT) in 2012 enabled us to grow beyond our core roots, both in size and service offerings. Today as BioTelemetry Research, we are a member of the world’s largest cardiac data network — processing over 2 billion heartbeats a day, while supporting more than 20,000 sites and 30,000 devices monthly, as well as monitoring over 500,000 patients a year. In addition to industry-leading global cardiovascular monitoring, we have now expanded our clinical trial services in two important areas: advanced imaging services and respiratory testing. Every day, our global services teams meet the demands of Phase I-IV trials for the world’s largest pharmaceutical organizations, specialty pharmaceutical firms, emerging biotechnology companies, and medical device manufacturers.



May 13, 2015

Blood Pressure Evaluation During Early Phase Trials

Daniel B. Goodman, MD, Michael A. Weber, MD; 3 Nov 2014

More attention is being paid to blood pressure (BP) effects in new chemical entities under development for non-hypertension indications, especially when these are not anticipated and not thoroughly defined during drug development.

More Publications



May 13-15, 2015

Heart Rhythm 2015

36th Annual Scientific Sessions
Boston Convention & Exhibition Center
Booth 819

More Events